Long-term safety and effectiveness of TSND-201 for PTSD
Part of Mental health clinical trials.
This trial checks the long-term safety and how well TSND-201, a study drug, helps people with PTSD. It is for patients who already completed a previous TSND-201 study and did well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have finished a previous Transcend-sponsored clinical trial for the study drug TSND-201 and be in good standing with the study site.
- You need to be able to talk and read well enough to complete interviews and questionnaires.
- You must agree not to join any other clinical trials for the duration of this study.
- You cannot have had any severe side effects from the study drug in the earlier trial.
- You should not have had any major problems following the rules in the earlier study.
- You must not have any new or worsening physical or mental health issues that make you unfit for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an investigational drug called TSND-201 can help treat PTSD. It is for people who have tried at least one other PTSD treatment before.
This early-phase study tests a responsive brain stimulation device to help people with chronic PTSD who have not improved with standard treatments. You would be closely followed for years, with regular assessments and device setting changes to see if symptoms improve.
This trial tests if a single infusion of allopregnanolone (a natural brain chemical) can help people with PTSD reduce fear responses and improve memory processing. It may offer a new way to treat PTSD by targeting how the brain stores traumatic memories.
This trial studies how a therapy called “prolonged exposure” works for people with post-traumatic stress disorder (PTSD). You may be able to join if you have PTSD, are interested in starting prolonged exposure, and meet other safety and participation rules.
This trial tests if adding a type of brain stimulation (TMS) to a memory reactivation therapy can reduce PTSD symptoms that haven't improved with standard antidepressants. If you have persistent PTSD, this study could offer a new treatment option.
This study tests a new therapy that uses short-term recall and reprocessing to help people with severe PTSD. It may help you if you have strong PTSD symptoms and are not currently in crisis or have certain other mental health conditions.
Hear when a new PTSD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.